Stock AnalizNutrien (NTR) earnings for the quarter ended September 2026: EPS misses estimates
Nutrien reported results for the quarter ended September 2026 on November 4, 2026. Adjusted earnings per share came in at $0.61 against the analysts’ average forecast of $0.78, a miss of 22.1%.
The market’s verdict: the stock rose 4.2% on the first trading day after the report.
The last four quarters
Nutrien has beaten the analysts’ EPS forecast in 0 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $0.61 | $0.78 | −22.1% | — | +4.2% |
| Jun 2026 | $2.61 | $2.72 | −3.9% | — | −0.2% |
| Mar 2026 | $0.51 | $0.55 | −7.0% | — | −11.5% |
| Dec 2025 | $0.83 | $0.91 | −8.6% | — | +2.8% |
What comes next
Analysts expect EPS of $0.94 for the next quarter on average and $4.71 for the fiscal year ending December 31, 2026.
The average analyst price target is $77.58, 9% above the current price of $71.24.
Valuation and score
Nutrien scores 2.8 out of 5 overall on Stock Analiz (average), trades at a trailing P/E of about 15.6, and its intrinsic value under moderate assumptions is about 39% below the current market value. Full Nutrien analysis with 10 years of financials
Frequently asked questions
What was Nutrien’s EPS for the quarter ended September 2026?
$0.61 adjusted per share, against an analyst consensus of $0.78.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.